beta-lactams has been researched along with Bone Diseases in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chidiac, C; Ferry, T; Laurent, F; Ragois, P | 1 |
Barnes, PD; Felder, KK; Marshall, LM; Vaz, LE | 1 |
Cohen, R | 1 |
Bernard, T; Buchanan, TC; Floyd, I; Haddad, RJ; Johnston, R; Longenecker, SL; Macey, TI; Mogabgab, WJ | 1 |
4 other study(ies) available for beta-lactams and Bone Diseases
Article | Year |
---|---|
Post-traumatic chronic bone and joint infection caused by Butyricimonas spp, and treated with high doses of ertapenem administered subcutaneously in a 30-year-old obese man.
Topics: Accidents, Traffic; Administration, Cutaneous; Adult; Anti-Bacterial Agents; Arm Injuries; Bacteria; beta-Lactams; Bone Diseases; Ertapenem; Fractures, Open; Humans; Infections; Joint Diseases; Male | 2015 |
Risk Factors for Complications during Outpatient Parenteral Antimicrobial Therapy for Adult Orthopedic and Neurosurgical Infections.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; beta-Lactams; Bone Diseases; Cohort Studies; Female; Humans; Injections, Intravenous; Male; Middle Aged; Nervous System Diseases; Outpatient Clinics, Hospital; Retrospective Studies; Risk Factors; Vancomycin; Young Adult | 2016 |
[Clinical implications of antibiotic pharmacokinetic-pharmacodynamic parameters].
Topics: Administration, Oral; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactam Resistance; beta-Lactams; Bone Diseases; Dose-Response Relationship, Drug; Drug Design; Drug Evaluation; Drug Resistance, Bacterial; Forecasting; Humans; Injections, Intravenous; Macrolides; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Respiratory Tract Infections; Risk Factors; Skin Diseases, Bacterial; Staphylococcus aureus; Streptococcus pneumoniae; Time Factors | 2008 |
Third-generation beta-lactam antibiotics for treatment of orthopedic infections.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Bone Diseases; Female; Humans; Joint Diseases; Male; Middle Aged | 1982 |